JP2010513434A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010513434A5 JP2010513434A5 JP2009542194A JP2009542194A JP2010513434A5 JP 2010513434 A5 JP2010513434 A5 JP 2010513434A5 JP 2009542194 A JP2009542194 A JP 2009542194A JP 2009542194 A JP2009542194 A JP 2009542194A JP 2010513434 A5 JP2010513434 A5 JP 2010513434A5
- Authority
- JP
- Japan
- Prior art keywords
- oxy
- azoniabicyclo
- octane
- alkyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC1(C)C(CC2)*[N+]2(*)CC1 Chemical compound CC1(C)C(CC2)*[N+]2(*)CC1 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87063806P | 2006-12-19 | 2006-12-19 | |
| PCT/GB2007/004817 WO2008075005A1 (en) | 2006-12-19 | 2007-12-17 | Quinuclidinol derivatives as muscarinic receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010513434A JP2010513434A (ja) | 2010-04-30 |
| JP2010513434A5 true JP2010513434A5 (enExample) | 2010-06-17 |
| JP4604129B2 JP4604129B2 (ja) | 2010-12-22 |
Family
ID=39166793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009542194A Expired - Fee Related JP4604129B2 (ja) | 2006-12-19 | 2007-12-17 | ムスカリン受容体アンタゴニストとしてのキヌクリジノール誘導体 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20100113510A1 (enExample) |
| EP (1) | EP2121137B1 (enExample) |
| JP (1) | JP4604129B2 (enExample) |
| KR (1) | KR20090094460A (enExample) |
| CN (1) | CN101610813A (enExample) |
| AR (1) | AR064414A1 (enExample) |
| AT (1) | ATE555111T1 (enExample) |
| AU (1) | AU2007336054A1 (enExample) |
| BR (1) | BRPI0721039A2 (enExample) |
| CA (1) | CA2672446A1 (enExample) |
| CL (1) | CL2007003690A1 (enExample) |
| CO (1) | CO6180439A2 (enExample) |
| EC (1) | ECSP099394A (enExample) |
| ES (1) | ES2385681T3 (enExample) |
| IL (1) | IL199015A0 (enExample) |
| MX (1) | MX2009006018A (enExample) |
| NO (1) | NO20092689L (enExample) |
| PE (1) | PE20081837A1 (enExample) |
| RU (1) | RU2009120229A (enExample) |
| TW (1) | TW200831507A (enExample) |
| UY (1) | UY30803A1 (enExample) |
| WO (1) | WO2008075005A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200825084A (en) | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
| GB0808707D0 (en) * | 2008-05-13 | 2008-06-18 | Argenta Discovery Ltd | New compounds 275 |
| MX2010012189A (es) | 2008-05-13 | 2011-03-02 | Astrazeneca Ab | Derivados de quinuclidina como antagonistas del receptor m3 muscarinico. |
| WO2009153536A1 (en) * | 2008-06-17 | 2009-12-23 | Argenta Discovery Limited | 1-aza-bicyclo [2.2.2] octane derivatives useful as muscarinic receptor antagonists |
| GB0811099D0 (en) * | 2008-06-17 | 2008-07-23 | Astrazeneca Ab | New combination 376 |
| GB0811100D0 (en) * | 2008-06-17 | 2008-07-23 | Astrazeneca Ab | New combination |
| WO2010008341A1 (en) * | 2008-07-16 | 2010-01-21 | Astrazeneca Ab | A combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist |
| EP2206712A1 (en) * | 2008-12-23 | 2010-07-14 | CHIESI FARMACEUTICI S.p.A. | "Alkaloid aminoester derivatives and medicinal composition thereof" |
| TW201036957A (en) | 2009-02-20 | 2010-10-16 | Astrazeneca Ab | Novel salt 628 |
| WO2010144043A1 (en) * | 2009-06-12 | 2010-12-16 | Astrazeneca Ab | A novel 4-methylbenzenesulphonate salt and a process for preparing a pharmaceutical composition comprising the salt |
| AU2010280323A1 (en) | 2009-07-31 | 2012-03-08 | Cadila Healthcare Limited | Novel compounds as modulators of glucocorticoid receptors |
| WO2011073662A1 (en) | 2009-12-17 | 2011-06-23 | Astrazeneca Ab | Combination of a benzoxazinone and a further agent for treating respiratory diseases |
| KR20130111968A (ko) * | 2010-06-22 | 2013-10-11 | 키에시 파르마슈티시 엣스. 피. 에이. | 알칼로이드 아미노에스테르 유도체 및 이의 의약 조성물 |
| CN102947299B (zh) * | 2010-06-22 | 2015-07-15 | 奇斯药制品公司 | 生物碱氨基酯衍生物及其药物组合物 |
| CN104011043B (zh) * | 2011-12-30 | 2016-11-16 | 奇斯药制品公司 | 作为抗毒蕈碱剂的1-氮杂杂环基乙酸的奎宁环酯、它们的制备方法及其药用组合物 |
| AU2014292722B2 (en) * | 2013-07-13 | 2017-03-09 | Beijing Showby Pharmaceutical Co., Ltd. | Quinine compounds, and optical isomers, preparation method and medical use thereof |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8334494D0 (en) | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
| GB8923590D0 (en) * | 1989-10-19 | 1989-12-06 | Pfizer Ltd | Antimuscarinic bronchodilators |
| GR1001529B (el) | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| DE69720965T2 (de) | 1996-02-13 | 2004-02-05 | Astrazeneca Ab | Chinazolinderivate und deren verwendung als vegf hemmer |
| PT885198E (pt) | 1996-03-05 | 2002-06-28 | Astrazeneca Ab | Derivados de 4-anilinoquinazolina |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| CA2406979A1 (en) | 2000-05-31 | 2001-12-06 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| GB0015876D0 (en) | 2000-06-28 | 2000-08-23 | Novartis Ag | Organic compounds |
| CZ200331A3 (cs) | 2000-07-07 | 2003-04-16 | Angiogene Pharmaceuticals Limited | Deriváty kolchinolu jako inhibitory angiogeneze, způsob jejich přípravy a farmaceutická kompozice, která je obsahuje |
| IL153484A0 (en) | 2000-07-07 | 2003-07-06 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors |
| WO2002076933A1 (en) | 2001-03-22 | 2002-10-03 | Glaxo Group Limited | Formailide derivatives as beta2-adrenoreceptor agonists |
| EP2039700A2 (en) | 2001-04-30 | 2009-03-25 | Glaxo Group Limited | Novel anti-inflammatory androstane derivatives |
| US20030229058A1 (en) | 2001-11-13 | 2003-12-11 | Moran Edmund J. | Aryl aniline beta2 adrenergic receptor agonists |
| TWI249515B (en) | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
| KR20050047552A (ko) | 2002-10-11 | 2005-05-20 | 화이자 인코포레이티드 | 베타-2 작용제로서의 인돌 유도체 |
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| AR044134A1 (es) * | 2003-05-02 | 2005-08-24 | Novartis Ag | Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas. |
| CN100445281C (zh) * | 2003-05-02 | 2008-12-24 | 诺瓦提斯公司 | 与毒蕈碱性m3受体结合的奎宁环衍生物 |
| CN100450488C (zh) | 2003-11-03 | 2009-01-14 | 诺顿·希尔思凯尔有限公司 | 用于干粉吸入剂的软类固醇组合物 |
| CA2584413A1 (en) | 2004-10-29 | 2006-05-04 | Astrazeneca Ab | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| GB0424284D0 (en) * | 2004-11-02 | 2004-12-01 | Novartis Ag | Organic compounds |
| TW200722418A (en) * | 2005-04-20 | 2007-06-16 | Astrazeneca Ab | Novel compounds |
-
2007
- 2007-12-17 KR KR1020097014992A patent/KR20090094460A/ko not_active Withdrawn
- 2007-12-17 JP JP2009542194A patent/JP4604129B2/ja not_active Expired - Fee Related
- 2007-12-17 ES ES07848557T patent/ES2385681T3/es active Active
- 2007-12-17 BR BRPI0721039-6A patent/BRPI0721039A2/pt not_active IP Right Cessation
- 2007-12-17 WO PCT/GB2007/004817 patent/WO2008075005A1/en not_active Ceased
- 2007-12-17 RU RU2009120229/15A patent/RU2009120229A/ru not_active Application Discontinuation
- 2007-12-17 AT AT07848557T patent/ATE555111T1/de active
- 2007-12-17 CA CA002672446A patent/CA2672446A1/en not_active Abandoned
- 2007-12-17 CN CNA2007800514963A patent/CN101610813A/zh active Pending
- 2007-12-17 AU AU2007336054A patent/AU2007336054A1/en not_active Abandoned
- 2007-12-17 US US12/518,185 patent/US20100113510A1/en not_active Abandoned
- 2007-12-17 EP EP07848557A patent/EP2121137B1/en active Active
- 2007-12-17 MX MX2009006018A patent/MX2009006018A/es not_active Application Discontinuation
- 2007-12-18 CL CL200703690A patent/CL2007003690A1/es unknown
- 2007-12-18 TW TW096148391A patent/TW200831507A/zh unknown
- 2007-12-18 AR ARP070105689A patent/AR064414A1/es unknown
- 2007-12-18 UY UY30803A patent/UY30803A1/es unknown
-
2008
- 2008-01-02 PE PE2008000007A patent/PE20081837A1/es not_active Application Discontinuation
-
2009
- 2009-05-27 IL IL199015A patent/IL199015A0/en unknown
- 2009-05-28 CO CO09054972A patent/CO6180439A2/es not_active Application Discontinuation
- 2009-06-08 EC EC2009009394A patent/ECSP099394A/es unknown
- 2009-07-15 NO NO20092689A patent/NO20092689L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010513434A5 (enExample) | ||
| JP7398391B2 (ja) | Ｎ－［４－オキソ－２，３－ジヒドロ－１，５－ベンズオキサゼピン－３－イル］－５，６－ジヒドロ－４Ｈ－ピロロ［１，２－ｂ］ピラゾール－２－カルボキサミド誘導体及び例えば過敏性腸症候群（ＩＢＳ）を処置するためのＲＩＰ１キナーゼ阻害剤としての関連化合物 | |
| RU2746129C2 (ru) | Биарильные монобактамные соединения и способы их применения для лечения бактериальных инфекций | |
| JP2005533826A5 (enExample) | ||
| JP4505227B2 (ja) | １−アルキル−１−アゾニアビシクロ［２．２．２］オクタンカルバメート誘導体およびムスカリンレセプターアンタゴニストとしてのそれらの使用 | |
| RU2009120229A (ru) | Производные хинуклидинола в качестве антагонистов мускариновых рецепторов | |
| US7718670B2 (en) | Quinuclidine amide derivatives | |
| JP4853918B2 (ja) | グリシン輸送阻害剤としての三環式化合物の使用 | |
| RU2399620C2 (ru) | Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3 | |
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| JP6505023B2 (ja) | Ｃｎｓおよび他の障害を治療するための、ｐｄｅ４アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物 | |
| TWI629276B (zh) | 咪唑并嗒化合物 | |
| JP2008509187A5 (enExample) | ||
| JP2008500990A5 (enExample) | ||
| JP7367038B2 (ja) | Ｌｐａ１受容体のイメージングのための放射性リガンド | |
| WO2015196071A9 (en) | Compounds, compositions and methods of increasing cftr activity | |
| JP2008500988A5 (enExample) | ||
| CN1152870A (zh) | 杂环化合物作为多巴胺d3配位体的用途 | |
| JP2010509391A5 (enExample) | ||
| HU228594B1 (en) | Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same | |
| CA2401502A1 (en) | Carboxylic acid derivatives as ip antagonists | |
| WO2016115090A1 (en) | Compounds, compositions and methods for increasing cftr activity | |
| JP5552121B2 (ja) | ロイコトリエン産生のインドリジン阻害剤 | |
| WO2017040606A1 (en) | Isoxazole derivatives for use in the treatment of pulmonary diseases and disorders | |
| AU2013358591A1 (en) | Pyrimido [4,5-b]quinoline-4,5 (3H,10H)-diones as nonsense mutation suppressors |